Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.400
+0.400 (10.00%)
Sep 4, 2026, 4:00 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$6,989
Profits / Employee
-$681,284
Market Cap
878.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 142 |
| Northwest Biotherapeutics | 105 |
| Vaxart | 65 |
| CytoDyn | 13 |
| Nuo Therapeutics | 10 |
| Cell Source | 1 |
Silence Therapeutics News
- 5 days ago - Silence Therapeutics Slides: Corporate presentation - Filings
- 6 days ago - Silence Therapeutics to Participate in Three September Investor Conferences - Business Wire
- 22 days ago - Silence Therapeutics 13M share Secondary priced at $13.50 - TheFly
- 22 days ago - Silence Therapeutics 13M share Secondary priced at $13.50 - TheFly
- 25 days ago - Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs - Business Wire
- 27 days ago - Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering - Business Wire
- 4 weeks ago - Silence Therapeutics price target raised to $32 from $25 at Morgan Stanley - TheFly
- 4 weeks ago - Silence Therapeutics files to sell $150M in ADS’s - TheFly